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Case Summary
A 53-year-old man with nonischemic car-
diomyopathy, left bundle branch block QRS mor-
phology, and congestive heart failure underwent
biventricular implantable cardioverter defibrilla-
tor (ICD) (Model V365; St. Jude Medical Cor-
poration, Sunnyvale, CA, USA) placement for
primary prevention of sudden cardiac death. The
device was programmed with two zones: ventric-
ular fibrillation (VF) zone at 210 bpm (285 ms)
and ventricular tachycardia (VT) zone at
170 bpm (352 ms). Detection enhancement was
programmed on to diagnose VT if any of the dis-
criminators (“Rate Branch,” “Morphology,” and
“Sudden Onset”) indicated VT. ICD interrogation
during the routine follow-up visit revealed an
episode of tachycardia with 1:1 atrioventricular
(AV) relationship (Fig. 1). The tachycardia cycle
length was initially slightly longer than the VT
detection limit and gradually became shorter than
VT detection limit. “Rate Branch” and “Sudden
Onset” discriminators indicated supraventricular
tachycardia (SVT). However, none of eight tachy-
cardia beats matched the template as indicated by
the “X” markers. Therefore, VT was detected and
successfully terminated by antitachycardia pac-
ing (ATP) therapy. What is the mechanism of the
tachycardia?
Commentary
The possible mechanisms of tachycardia with
1:1 AV relationship are VT with retrograde AV
nodal conduction or SVT. During ATP therapy,
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the ventricle is paced at a much shorter cycle
length without significant changes in the atrial
cycle length until the last beat before the tachy-
cardia terminates. Because the atrial rate does not
change during ATP, it rules in SVT. Isorhyth-
mic VT and SVT are unlikely because there is a
strong ventriculoatrial relationship despite tachy-
cardia cycle length variability. VT in this pa-
tient is diagnosed by the device from morphology
mismatch, which could be due to aberrant con-
duction or algorithm error. The possible mecha-
nisms of the SVT include: sinus tachycardia, AV
reentry tachycardia, AV nodal reentry tachycar-
dia, and atrial tachycardia. AV reentry tachycar-
dia is ruled out because of the presence of AV
dissociation during ATP before the tachycardia
terminates. There is significant tachycardia cy-
cle length variation seen at the beginning of the
tracing (4th, 5th, and 6th beats). Because atrial cy-
cle length is predicted by the preceding ventric-
ular cycle length, sinus tachycardia and atrial
tachycardia are excluded.1 Therefore, the mech-
anism of this tachycardia is AV nodal reentry
tachycardia.
Inappropriate ICD therapy is the most com-
mon ICD complication. The additional atrial in-
formation provided by dual-chamber devices can
reduce the incidence of inappropriate therapy
due to atrial fibrillation or atrial tachyarrhyth-
mia when the atrial rate is faster than ven-
tricular rate. However, it is more difficult to
discriminate SVT from VT when the tachycar-
dia exhibits a 1:1 AV relationship. Despite sup-
plemental information from atrial leads and so-
phisticated algorithms, the ICD can still fail to
recognize SVT and inappropriately deliver thera-
pies. Through careful review of the atrial and ven-
tricular relationship during the tachycardia, cycle
length variation and ATP therapy can help to dis-
tinguish the tachycardia mechanism, as demon-
strated in this case. Since the patient had only one
episode of AV nodal reentry tachycardia, we de-
cided to treat conservatively and recommended
catheter ablation procedure only in the case of
recurrence.
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Figure 1. Episode details (top) and stored intracardiac electrograms (bottom).
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